• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Inovio Pharma (NQ: INO )

    7.370 -0.490 (-6.23%)
    Streaming Delayed Price Updated: 3:49 PM EDT, Aug 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Inovio Pharma

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    2 Things That May Boost This Beaten-Down Vaccine Stock
    This company could benefit from a near-term need -- and a long-term one, as well. 
    Via The Motley Fool
    High Flyers At Much Lower Altitudes
    Stocks with extreme valuations have taken a serious haircut since the space peaked on February 22nd. 
    Via Talk Markets
    1 Coronavirus Vaccine Company to Avoid Like The Plague in May (and Beyond)
    This biotech's prospects look dim. 
    Via The Motley Fool
    Exposures COVID-19
    Inovio's Pan-COVID-19 Vaccine Candidate Can Provide Immune Responses Against Variants, Animal Study Shows
    Inovio Pharmaceuticals Inc (NASDAQ: INO) has announced results from a preclinical study of its next-generation Pan-COVID-19 vaccine candidate, INO-4802, that... 
    Via Benzinga
    Novavax, Inovio Stocks Hammered As Covid Vaccine News Disappoints
    Vaccine stocks crumbled Tuesday after Novavax announced a delay and Inovio's Covid vaccine disappointed in testing. Both NVAX stock and INO stock plunged. 
    Via Investor's Business Daily
    Earnings Scheduled For May 10, 2021
    Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report... 
    Via Benzinga
    The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... 
    Via Benzinga
    Exposures COVID-19
    Stocks That Hit 52-Week Lows On Tuesday
    Before 10 a.m. ET Tuesday, 173 stocks hit new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Snowflake (NYSE:SNOW... 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Gainers Cerecor (NASDAQ:CERC) shares rose 14.56% to $2.91 during Tuesday's pre-market session. The company's market cap stands at $281.4 million. Larimar... 
    Via Benzinga
    Inovio Pharmaceuticals (INO) Q1 2021 Earnings Call Transcript
    INO earnings call for the period ending March 31, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Recap: Inovio Pharmaceuticals Q1 Earnings
    Shares of Inovio Pharmaceuticals (NASDAQ:INO) decreased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share decreased 3.85% over... 
    Via Benzinga
    Inovio's DNA COVID-19 Vaccine Candidate Triggers Immune Response In Pivotal Study
    Inovio Pharmaceuticals Inc (NASDAQ: INO) has announced positive data from the Phase 2 segment of its Phase 2/3 INNOVATE trial in the U.S.,... 
    Via Benzinga
    Exposures COVID-19
    20 Stocks Moving in Monday's Pre-Market Session
    Gainers Alfi, Inc. (NASDAQ: ALF) shares rose 30.3% to $4.82 in pre-market trading. The company recently appointed Ron Spears as Chief Revenue Officer. SemiLEDs Corporation (... 
    Via Benzinga
    The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -... 
    Via Benzinga
    Exposures COVID-19 Product Safety
    The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
    Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
    Via Benzinga
    Exposures COVID-19 Product Safety
    Preview: Inovio Pharmaceuticals's Earnings
    Inovio Pharmaceuticals (NASDAQ:INO) announces its next round of earnings this Monday, May 10. Here is Benzinga's everything-that-matters guide for this Monday's Q1 earnings... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
    On Tuesday morning, 58 companies hit new 52-week lows. Points of Interest: The largest company by market cap to set a new 52-week low was Lufax Holding (NYSE:LU).... 
    Via Benzinga
    Cramer Weighs In On Coinbase, Kellogg And More
    Jim Cramer said on CNBC's "Mad Money Lightning Round" that he has always felt that Ocugen Inc (NASDAQ: OCGN) is a great spec, but it's a heavily shorted stock... 
    Via Benzinga
    Can Inovio Recover From Its Huge Setback?
    It might be able to, although it won't be easy. 
    Via The Motley Fool
    Exposures COVID-19
    The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:... 
    Via Benzinga
    The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... 
    Via Benzinga
    Is There Any Hope for Inovio?
    Everything may depend on an early-stage program. 
    Via The Motley Fool
    Exposures COVID-19
    50 Biggest Movers From Friday
    Gainers Sypris Solutions, Inc. (NASDAQ: SYPR) shares surged 59.1% to close at $4.47 on Friday after the company said its electronics unit has won a contract for deep space... 
    Via Benzinga
    Market Briefing For Monday, Apr. 26
    Nasdaq is perking up, primarily led by FANG types reporting next week (discounted). So, higher a bit near-term; then, risks. 
    Via Talk Markets
    Mid-Afternoon Market Update: Nasdaq Surges 1.5%; EDAP Shares Plunge
    Toward the end of trading Friday, the Dow traded up 0.67% to 34,041.01 while the NASDAQ rose 1.54% to 14,031.45. The S&P also rose, gaining 1.16% to 4,182.83. The U.S. has the... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Mid-Day Market Update: Skechers Jumps On Earnings Beat; Inovio Pharmaceuticals Shares Drop
    Midway through trading Friday, the Dow traded up 0.52% to 33,992.56 while the NASDAQ rose 0.93% to 13,947.48. The S&P also rose, gaining 0.82% to 4,168.89. The U.S. has the... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    32 Stocks Moving In Friday's Mid-Day Session
    Gainers Sypris Solutions, Inc. (NASDAQ: SYPR) shares climbed 24.7% to $3.50 after the company said its electronics unit has won a contract for deep space program. MicroVision,... 
    Via Benzinga
    Inovio Stock Collapses After U.S. Officials Pull Funding For Covid Vaccine Test
    Inovio said Friday the Department of Defense pulled its funding for final-phase testing of the company's Covid vaccine, prompting INO stock to collapse. 
    Via Investor's Business Daily
    Why Inovio Stock Is Crashing Today
    The biotech just lost funding for the late-stage study of its COVID-19 vaccine candidate. 
    Via The Motley Fool
    Exposures COVID-19
    Stocks That Hit 52-Week Lows On Friday
    During the morning session on Friday, 6 stocks hit new 52-week lows. Facts of Interest: The company with the largest market cap to set a new 52-week low was Quidel... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.